Los Angeles Capital Management LLC Invitae Corp Transaction History

Los Angeles Capital Management LLC

$29.2 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.42 - $0.72 $11,449 - $19,627	-27,260 Reduced 72.13%	10,532 $6,000
Q3 2023 Nov 06, 2023	SELL	$0.6 - $1.53 $217,560 - $554,779	-362,601 Reduced 90.56%	37,792 $22,000
Q2 2023 Aug 03, 2023	SELL	$1.05 - $1.63 $23,634 - $36,689	-22,509 Reduced 5.32%	400,393 $452,000
Q1 2023 May 04, 2023	SELL	$1.2 - $2.73 $10,454 - $23,783	-8,712 Reduced 2.02%	422,902 $570,000
Q4 2022 Feb 06, 2023	BUY	$1.71 - $3.61 $362,306 - $764,868	211,875 Added 96.42%	431,614 $802,000

Q3 2022 Nov 02, 2022	BUY	$1.9 - $8.63 $324,185 - $1.47 Million	170,624 Added 347.4%	219,739 $541,000
Q2 2022 Aug 05, 2022	BUY	$2.13 - $9.01 $32,848 - $138,952	15,422 Added 45.77%	49,115 $120,000
Q1 2022 May 06, 2022	BUY	$6.28 - $15.59 $111,375 - $276,488	17,735 Added 111.14%	33,693 $269,000
Q4 2021 Feb 03, 2022	SELL	$14.7 - $28.67 $53,390 - $104,129	-3,632 Reduced 18.54%	15,958 $244,000
Q3 2021 Nov 08, 2021	BUY	$24.31 - $33.6 $24,917 - $34,440	1,025 Added 5.52%	19,590 $557,000
Q2 2021 Aug 05, 2021	SELL	$26.09 - $40.4 $21,132 - $32,724	-810 Reduced 4.18%	18,565 $626,000
Q1 2021 May 05, 2021	SELL	$33.06 - $56.93 $383,727 - $660,786	-11,607 Reduced 37.46%	19,375 $740,000
Q4 2020 Feb 04, 2021	BUY	$39.09 - $57.4 $235,712 - $346,122	6,030 Added 24.17%	30,982 $1.3 Million
Q3 2020 Nov 02, 2020	BUY	$28.43 - $44.67 $316,141 - $496,730	11,120 Added 80.39%	24,952 $1.08 Million
Q2 2020 Aug 05, 2020	BUY	$11.71 - $30.29 $161,972 - $418,971	13,832 New	13,832 $418,000
Q2 2019 Jul 29, 2019	SELL	$17.37 - $26.27 $191,938 - $290,283	-11,050 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$10.65 - $25.75 $117,682 - $284,537	11,050 New	11,050 $259,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account